$ZTEK

Zentek Ltd.

No enriched coverage for $ZTEK in the last 7 days.

No SEC Form 4 filings for $ZTEK in the last 30 days.

Med

Zentek Ltd stock (CA98936C1068): Why does its graphene tech matter more for U.S. investors now?

Zentek Ltd, a Canadian company traded over-the-counter in the U.S. (ZENYF), specializes in graphene-based technologies with applications in antimicrobials and air filtration. The article highlights why its innovative solutions, particularly ZenGUARD and Hydrozen, are becoming increasingly relevant for U.S. investors due to growing demand for sustainable tech and addressing public health and environmental concerns. Despite sparse analyst coverage typical for small-cap stocks, Zentek's alignment with U.S. market trends and B2B sales strategy presents a speculative opportunity for those tracking advanced materials innovation.

Court rejects $6M claims against Zentek (NASDAQ: ZTEK) in Ontario ruling

Zentek (NASDAQ: ZTEK) has successfully defended itself against claims exceeding $6 million in a long-standing litigation with its former CEO. The Ontario Superior Court dismissed substantially all claims, including those for a success fee, severance, unpaid wages, defamation, and indemnification. This favorable outcome allows Zentek to focus on its core platforms: Albany Graphite, ZenGUARD™, and Triera.